EX-2.1
from 8-K
119 pages
Agreement and Plan of Merger, Dated as of November 15, 2012, by and Among Allergan, Inc., Aphrodite Acquisition, Inc., Skinmedica, Inc., and David F. Hale, as Equityholders’ Representative
12/34/56
EX-2.1
from 8-K
112 pages
Agreement and Plan of Merger Dated as of July 18, 2011 by and Among Allergan, Inc., Erythema Acquisition, Inc., Vicept Therapeutics, Inc. and Neal Walker as Shareholders’ Representative
12/34/56
EX-2.1
from 8-K/A
276 pages
Agreement and Plan of Merger Dated as of September 18, 2007 by and Among Allergan, Inc., Esmeralde Acquisition, Inc., Esprit Pharma Holding Company, Inc. and Escrow Participants’ Representative
12/34/56